JACOBS LEVY EQUITY MANAGEMENT, INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 205 filers reported holding CARDLYTICS INC in Q4 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.9%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$3,463,994
+51.9%
209,939
-41.8%
0.02%
+61.5%
Q2 2023$2,280,629
+60.6%
360,859
-13.7%
0.01%
+44.4%
Q1 2023$1,419,955
-40.9%
418,249
+0.7%
0.01%
-43.8%
Q4 2022$2,400,637
+288.5%
415,335
+9496.5%
0.02%
+220.0%
Q4 2020$618,0004,3280.01%
Other shareholders
CARDLYTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders